Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-07-17 Option Award |
2024-07-19 4:32 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
925 | $0 | 925 (Direct) |
View |
2024-06-01 Exercise |
2024-06-03 4:58 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
88 | $0 | 217 (Direct) |
View |
2023-08-09 Exercise |
2023-08-10 4:12 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
3,571 | $0 | 5,682 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 4:44 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
3,571 | $0 | 5,980 (Direct) |
View |
2023-06-01 Exercise |
2023-06-02 4:44 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
297 | $0 | 5,980 (Direct) |
View |
2022-08-09 Option Award |
2022-08-10 4:06 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
3,571 | $0 | 3,571 (Direct) |
View |
2021-06-01 Option Award |
2021-06-02 7:35 pm |
N/A 2031-06-01 |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
3,571 | $0 | 3,571 (Direct) |
View |
2020-07-02 Option Award |
2021-02-17 9:03 pm |
N/A 2030-07-02 |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
3,571 | $0 | 3,571 (Direct) |
View |
2020-07-27 Option Award |
2020-07-29 9:39 pm |
N/A 2030-07-26 |
Aptevo Therapeutics Inc. | APVO | Niederhuber John Director |
1,492 | $0 | 1,492 (Direct) |
View |